Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Lawrence Fong, Andrew Hotson, John D. Powderly et al. · Cancer Discovery · 2019 · 321 citations · Full text

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

Paul A. Beavis, Nicole Milenkovski, Melissa A. Henderson et al. · Cancer Immunology Research · 2015 · 314 citations

Immunology, Immune Regulation, Immunoediting +18

Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment

Caglar Cekic, Yuan‐Ji Day, Duygu Sağ et al. · Cancer Research · 2014 · 282 citations · Full text

A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes

Alberto L. Horenstein, Antonella Chillemi, Gianluca Zaccarello et al. · OncoImmunology · 2013 · 265 citations · Full text

Chemotherapy induces ATP release from tumor cells

Isabelle Martins, Antoine Tesnière, Oliver Kepp et al. · Cell Cycle · 2009 · 264 citations